We recently published an article titled Jim Cramer Looked Closely At These 10 Stocks. In this article, we are going to take a ...

Elanco Animal Health is making progress on debt repayment ... In addition, Elanco gained FDA approvals of two new products, Zenrelia and Credelio Quattro, and acquired a Speke contract ...

The product's safety profile for puppies as small as 3.3 pounds ... the expanding AD market offer for Elanco's products? The atopic dermatitis (AD) market in animals is showing signs of expansion ...

Shares of Elanco Animal Health Incorporated (NYSE:ELAN – Get Free Report) have received a consensus rating of “Hold” from the eight research firms that are covering the firm, MarketBeat reports. One ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Short interest in Elanco Animal Health Inc (NYSE:ELAN) decreased during the last reporting period, falling from 15.63M to 15.21M. This put 4.93% of the company's publicly available shares short.

In this article, we are going to take a look at where Elanco Animal Health Incorporated (NYSE:ELAN) stands against the other best medical stocks under $20. The medical industry plays a crucial ...

Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes between Zenrelia and Apoquel® (oclacitinib tablet) ...

FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.